Maximal blockade of TxA2 without compromised PGR formation; a superior profile of the TxA2 receptor blocking drug over aspirin - Lumley, P; Keery, R J; Wharton, K A; White, B P; Warts, I S (Adv Prost Thromb Leukotriene Res, 1991)
In: